$BURU
Nuburu, Inc.

2021 Q2 Form 10-Q Financial Statement

#000110465921108187 Filed on August 20, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $1.504M $1.000K
YoY Change 150264.0%
Operating Profit -$1.504M -$1.000K
YoY Change 150264.3%
Interest Expense $13.68K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$8.702M
YoY Change
Pretax Income -$10.21M -$1.000K
YoY Change 1020451.9%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.21M -$1.000K
YoY Change 1020451.9%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$244.3K -$23.78
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.468M $0.00
YoY Change
Cash & Equivalents $1.468M $0.00
Short-Term Investments
Other Short-Term Assets $185.4K $100.0K
YoY Change 85.42%
Inventory
Prepaid Expenses $185.4K
Receivables
Other Receivables
Total Short-Term Assets $1.653M $100.0K
YoY Change 1553.33%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $334.4M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $334.4M $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $1.653M $100.0K
Total Long-Term Assets $334.4M $0.00
Total Assets $336.0M $100.0K
YoY Change 335938.32%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $3.773M $100.0K
YoY Change 3673.37%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.773M $100.0K
YoY Change 3673.37%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $47.35M
YoY Change
Total Long-Term Liabilities $47.35M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.773M $100.0K
Total Long-Term Liabilities $47.35M $0.00
Total Liabilities $51.13M $100.0K
YoY Change 51025.48%
SHAREHOLDERS EQUITY
Retained Earnings -$20.82M
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$49.30M $0.00
YoY Change
Total Liabilities & Shareholders Equity $336.0M $100.0K
YoY Change 335938.32%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$10.21M -$1.000K
YoY Change 1020451.9%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$489.9K -$1.000K
YoY Change 48887.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $25.00K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 25.00K
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -489.9K -1.000K
Cash From Investing Activities
Cash From Financing Activities 0.000 25.00K
Net Change In Cash -489.9K 24.00K
YoY Change -2141.13%
FREE CASH FLOW
Cash From Operating Activities -$489.9K -$1.000K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Central Index Key
EntityCentralIndexKey
0001814215
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-17900526
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000004
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39489
dei Entity Registrant Name
EntityRegistrantName
TAILWIND ACQUISITION CORP.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1288435
dei Entity Address Address Line1
EntityAddressAddressLine1
1545 Courtney Ave
dei Entity Address City Or Town
EntityAddressCityOrTown
Los Angeles
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90046
dei City Area Code
CityAreaCode
646
dei Local Phone Number
LocalPhoneNumber
432-0610
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1467915
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2245798
CY2021Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
185417
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
275652
CY2021Q2 us-gaap Assets Current
AssetsCurrent
1653332
CY2020Q4 us-gaap Assets Current
AssetsCurrent
2521450
CY2021Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334384989
CY2020Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
334321131
CY2021Q2 us-gaap Assets
Assets
336038321
CY2020Q4 us-gaap Assets
Assets
336842581
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3664367
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
208129
CY2021Q2 twnd Accrued Offering Costs
AccruedOfferingCosts
109000
CY2020Q4 twnd Accrued Offering Costs
AccruedOfferingCosts
126000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
3773367
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
334129
CY2021Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
35654560
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Fair Value Of Shares
SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares
36975099
CY2021Q2 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2020Q4 twnd Deferred Underwriting Fees Noncurrent
DeferredUnderwritingFeesNoncurrent
11697550
CY2021Q2 us-gaap Liabilities
Liabilities
51125477
CY2020Q4 us-gaap Liabilities
Liabilities
49006778
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
279912840
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
282835800
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25822110
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22899179
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20823485
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000003
CY2021Q1 twnd Common Stock Subject To Possible Redemption Value
CommonStockSubjectToPossibleRedemptionValue
-51379900
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
7282560
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
5000003
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
336038321
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
336842581
CY2021Q2 twnd Formation And Operating Costs
FormationAndOperatingCosts
1503643
twnd Formation And Operating Costs
FormationAndOperatingCosts
4307356
CY2020Q2 twnd Formation And Operating Costs
FormationAndOperatingCosts
1000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1503643
us-gaap Operating Income Loss
OperatingIncomeLoss
-4307356
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
13683
us-gaap Investment Income Interest
InvestmentIncomeInterest
63858
CY2021Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
8715559
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1320539
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-8701876
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1384397
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10205519
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2922959
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10205519
us-gaap Net Income Loss
NetIncomeLoss
-2922959
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-39097337
CY2021Q2 twnd Common Stock Subject To Possible Redemption Value
CommonStockSubjectToPossibleRedemptionValue
54302860
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-10205519
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
5000004
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
0
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-1000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
24000
us-gaap Profit Loss
ProfitLoss
-2922959
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-1000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1320539
us-gaap Investment Income Interest
InvestmentIncomeInterest
63858
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-90235
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3456238
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-760883
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1000
CY2020Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-17000
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-777883
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
24000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2245798
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1467915
us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1
CY2021Q2 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
675
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
24000
twnd Change In Value Of Common Stock Subject To Possible Redemption
ChangeInValueOfCommonStockSubjectToPossibleRedemption
-2922860
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. One of the more significant accounting estimates included in these financial statements is the determination of the fair value of the warrant liabilities. Such estimates may be subject to change as more current information becomes available and accordingly the actual results could differ significantly from those estimates. Accordingly, the actual results could differ significantly from those estimates.</p>
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
27991284
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
28283580
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
950000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
59000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Concentration of Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p>
CY2021Q2 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334384314
CY2020Q4 twnd Marketable Securities Held In Trust Account
MarketableSecuritiesHeldInTrustAccount
1138
CY2020Q4 twnd Cash Held In Trust Account
CashHeldInTrustAccount
334319993
CY2021Q2 twnd Deferred Underwriting Commissions
DeferredUnderwritingCommissions
11697550
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13580000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
3686000
CY2021Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
9894000
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
9894000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
9894000

Files In Submission

Name View Source Status
0001104659-21-108187-index-headers.html Edgar Link pending
0001104659-21-108187-index.html Edgar Link pending
0001104659-21-108187.txt Edgar Link pending
0001104659-21-108187-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
twnd-20210630.xsd Edgar Link pending
twnd-20210630x10q.htm Edgar Link pending
twnd-20210630x10q_htm.xml Edgar Link completed
twnd-20210630xex31d1.htm Edgar Link pending
twnd-20210630xex31d2.htm Edgar Link pending
twnd-20210630xex32d1.htm Edgar Link pending
twnd-20210630xex32d2.htm Edgar Link pending
twnd-20210630_cal.xml Edgar Link unprocessable
twnd-20210630_def.xml Edgar Link unprocessable
twnd-20210630_lab.xml Edgar Link unprocessable
twnd-20210630_pre.xml Edgar Link unprocessable